0001104659-19-059119 Sample Contracts

INDEMNIFICATION AGREEMENT
Indemnification Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York

This Indemnification Agreement (this “Agreement”) is entered into as of by and between Qilian International Holding Group Limited, a Cayman Islands company (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.

AutoNDA by SimpleDocs
EMPLOYMENT AGREEMENT
Employment Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations

This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of June 6, 2019 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Zhanchang Xin, an individual (the “Chief Technology Officer (CEO)”). Except with respect to the direct employment of the CEO by the Company, the term “Company” as used herein with respect to all obligations of the CEO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).

EQUITY PLEDGE AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. May 20, 2019 EQUITY PLEDGE AGREEMENT
Equity Pledge Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations

This EQUITY PLEDGE AGREEMENT (hereinafter, this "AGREEMENT") is entered into as of May 20, 2019 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:

THE AMENDED EXCLUSIVE SERVICE AGREEMENT AMONG CHENGDU QILIAN TRADING CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. August 27, 2019 THE AMENDED EXCLUSIVE SERVICE AGREEMENT
Exclusive Service Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations

This AMENDED EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of August 27, 2019(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:

CALL OPTION AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date]
Call Option Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations

This CALL OPTION AGREEMENT (this “AGREEMENT”) is entered into as of 【 , 2019】(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:

SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date] SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT
Shareholder Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations

This SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT (this “AGREEMENT”) is entered into as of [Date] (“SIGNING DATE”) in [City], the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!